U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H10O3
Molecular Weight 238.2381
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 7-HYDROXYFLAVONE

SMILES

OC1=CC2=C(C=C1)C(=O)C=C(O2)C3=CC=CC=C3

InChI

InChIKey=MQGPSCMMNJKMHQ-UHFFFAOYSA-N
InChI=1S/C15H10O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-9,16H

HIDE SMILES / InChI
7-hydroxyflavone belongs to the flavone subgroup of flavonoids. It is a potent inhibitor of 20alpha-hydroxysteroid dehydrogenase (AKR1C1), aromatase (cytochrome P450 19; CYP19), aldo-keto reductases AKR1B10 and AKR1B1. It can inhibit LPS-induced inflammation via attenuating the production of NO, PGE2, TNF-alpha and IL-6, indicating that it may be lead compound for developing anti-inflammatory agent. 7-hydroxyflavone may serve as potential protective agents in the treatment of patients with chronic EV71 infection.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
2.3 µM [IC50]
12.3 µM [IC50]
8.3 µM [IC50]
Target ID: 3C proteases of Enterovirus 71
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
In vitro effects of some flavones on human pyruvate kinase isoenzyme M2.
2015-03
Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
2010-12-20
Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations.
2010-10-15
Structure-affinity relationship of flavones on binding to serum albumins: effect of hydroxyl groups on ring A.
2010-07
Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.
2010-06-07
Comprehensive review of Clerodendrum phlomidis: a traditionally used bitter.
2010-06
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
2010-06
2-(4-Bromo-phen-yl)-6-methyl-4H-1-benzopyran-4-one (4'-bromo-6-methyl-flavone).
2010-03-27
Methylation of dietary flavones increases their metabolic stability and chemopreventive effects.
2009-11-18
AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids.
2009-03-16
Mechanism of CYP2C9 inhibition by flavones and flavonols.
2009-03
Intestinal first-pass glucuronidation activities of selected dihydroxyflavones.
2009-01-21
Metabolism and pharmacokinetics of 3,3',4',7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites.
2009-01-14
Ground and excited state proton transfer and antioxidant activity of 7-hydroxyflavone in model membranes: absorption and fluorescence spectroscopic studies.
2009-01
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids.
2008-09
Protein engineering on biphenyl dioxygenase for conferring activity to convert 7-hydroxyflavone and 5,7-dihydroxyflavone (chrysin).
2008-08
Empirically predicted 13C NMR chemical shifts for 8-hydroxyflavone starting from 7,8,4'-trihydroxyflavone and from 7,8-dihydroxyflavone.
2008-07
Phytoestrogens and breast cancer prevention: possible mechanisms of action.
2008-04
Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases.
2008-03
Interaction of 7-hydroxyflavone with human serum albumin: a spectroscopic study.
2008-01-30
Multi-substrate flavonol O-glucosyltransferases from strawberry (Fragaria x ananassa) achene and receptacle.
2008
Aromatase inhibition by bioavailable methylated flavones.
2007-10
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1.
2006-10-19
Methylated flavonoids have greatly improved intestinal absorption and metabolic stability.
2006-10
[Study on the non-covalent interaction of 7-hydroxy flavone and its phosphate with DNA by fluorescence method].
2006-03
Effect of different flavonoids on collagen synthesis in human fibroblasts.
2006-03
Microbial metabolism. Part 6. Metabolites of 3- and 7-hydroxyflavones.
2006-03
Characterization of polyphenols from plant materials through their silylation and 29Si NMR spectroscopy-line assignment through 29Si, 13C spin-spin couplings.
2005-10
Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
2004-11
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels.
2004-10
The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes.
2003-12-15
Manganese-based complexes of radical scavengers as neuroprotective agents.
2003-05-15
7-OH-flavone is sulfated in the human liver and duodenum, whereas 5-OH-flavone and 3-OH-flavone are potent inhibitors of SULT1A1 activity and 7-OH-flavone sulfation rate.
2002-07
Evaluation of 7-hydroxy-flavones as inhibitors of oestrone and oestradiol biosynthesis.
2001-11
No evidence for the in vivo activity of aromatase-inhibiting flavonoids.
2001-09
Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens.
2001-03
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
2001-01
Effect of simple phenolic compounds on azoxymethane-induced aberrant crypt foci in rat colon.
2001
Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
1994-09-01
Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds.
1994-08-03
Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases.
1990-07-05
Patents

Sample Use Guides

Rat: 40 mg/kg of bodyweight
Route of Administration: Intragastric
Renal proximal tubule (NRK52E) cells were pre-treated with 20 uM 7-Hydroxyflavone overnight prior to treatment with 200 uM nicotine and cell viability was determined 24 hours later. Nicotine significantly decreases cell viability, which was prevented by pretreatment with 7-Hydroxyflavone.
Name Type Language
NSC-94258
Preferred Name English
7-HYDROXYFLAVONE
Systematic Name English
4H-1-BENZOPYRAN-4-ONE, 7-HYDROXY-2-PHENYL-
Systematic Name English
7-HYDROXY FLAVONE
Systematic Name English
7-HYDROXY-2-PHENYL-4H-CHROMEN-4-ONE
Systematic Name English
2-PHENYL-CHROMEN-4-ONE
Systematic Name English
7--HYDROXY-2-PHENYL-4-BENZOPYRONE
Common Name English
HYDROXYFLAVONE, 7-
Systematic Name English
Code System Code Type Description
CAS
6665-86-7
Created by admin on Mon Mar 31 19:14:24 GMT 2025 , Edited by admin on Mon Mar 31 19:14:24 GMT 2025
PRIMARY
PUBCHEM
5281894
Created by admin on Mon Mar 31 19:14:24 GMT 2025 , Edited by admin on Mon Mar 31 19:14:24 GMT 2025
PRIMARY
ECHA (EC/EINECS)
229-705-3
Created by admin on Mon Mar 31 19:14:24 GMT 2025 , Edited by admin on Mon Mar 31 19:14:24 GMT 2025
PRIMARY
FDA UNII
ZE72458E4L
Created by admin on Mon Mar 31 19:14:24 GMT 2025 , Edited by admin on Mon Mar 31 19:14:24 GMT 2025
PRIMARY
NSC
94258
Created by admin on Mon Mar 31 19:14:24 GMT 2025 , Edited by admin on Mon Mar 31 19:14:24 GMT 2025
PRIMARY
CHEBI
2268
Created by admin on Mon Mar 31 19:14:24 GMT 2025 , Edited by admin on Mon Mar 31 19:14:24 GMT 2025
PRIMARY
EPA CompTox
DTXSID3022328
Created by admin on Mon Mar 31 19:14:24 GMT 2025 , Edited by admin on Mon Mar 31 19:14:24 GMT 2025
PRIMARY